CHAARM
Combined Highly Active Anti-retroviral Microbicides
| Coordinatore | KING'S COLLEGE LONDON
Organization address
address: Strand contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Totale costo | 17˙067˙499 € |
| EC contributo | 11˙999˙998 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2009-single-stage |
| Funding Scheme | CP-IP |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-01-01 - 2015-06-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
KING'S COLLEGE LONDON
Organization address
address: Strand contact info |
UK (LONDON) | coordinator | 1˙203˙352.90 |
| 2 |
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Organization address
address: RUE LEBLANC 25 contact info |
FR (PARIS 15) | participant | 1˙867˙938.80 |
| 3 |
KATHOLIEKE UNIVERSITEIT LEUVEN
Organization address
address: Oude Markt 13 contact info |
BE (LEUVEN) | participant | 899˙000.00 |
| 4 |
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE
Organization address
address: Nationalestraat 155 contact info |
BE (ANTWERPEN) | participant | 694˙000.40 |
| 5 |
Particle Sciences Inc.
Organization address
address: Courtney Street 3894 contact info |
US (Bethlehem) | participant | 503˙000.00 |
| 6 |
UNIVERSITY OF YORK
Organization address
address: HESLINGTON contact info |
UK (YORK NORTH YORKSHIRE) | participant | 460˙689.00 |
| 7 |
ST GEORGE'S HOSPITAL MEDICAL SCHOOL
Organization address
address: Cranmer Terrace contact info |
UK (LONDON) | participant | 432˙200.44 |
| 8 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | participant | 417˙799.53 |
| 9 |
UNIVERSITA' DEGLI STUDI DI SIENA
Organization address
address: VIA BANCHI DI SOTTO 55 contact info |
IT (SIENA) | participant | 399˙679.00 |
| 10 |
Fondazione Centro San Raffaele
Organization address
address: Via Olgettina 60 contact info |
IT (Milano) | participant | 367˙632.00 |
| 11 |
UNIVERSITEIT ANTWERPEN
Organization address
address: PRINSSTRAAT 13 contact info |
BE (ANTWERPEN) | participant | 336˙000.00 |
| 12 |
UNIVERSITAET BASEL
Organization address
address: Petersplatz 1 contact info |
CH (BASEL) | participant | 305˙000.00 |
| 13 |
INSTITUTO DE SALUD CARLOS III
Organization address
address: CALLE SINESIO DELGADO 4-6 contact info |
ES (MADRID) | participant | 300˙000.00 |
| 14 |
MIDDLESEX UNIVERSITY HIGHER EDUCATION CORPORATION
Organization address
address: THE BURROUGHS HENDON CAMPUS COLLEGE BUILDING contact info |
UK (LONDON) | participant | 300˙000.00 |
| 15 |
QUEEN'S UNIVERSITY BELFAST
Organization address
address: University Road contact info |
UK (BELFAST) | participant | 299˙854.00 |
| 16 |
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES
Organization address
address: PASEO MIRAMON PARQUE TECNOLOGICO DE SAN SEBASTIAN EDIFICIO EMPRESARIAL C 182 contact info |
ES (SAN SEBASTIAN) | participant | 299˙000.00 |
| 17 |
Spoluka Chemical Company Ltd
Organization address
address: Druzhbi Narodiv 9 contact info |
UA (Kiev) | participant | 299˙000.00 |
| 18 |
UNIVERSITE DE GENEVE
Organization address
address: Rue du General Dufour 24 contact info |
CH (GENEVE) | participant | 299˙000.00 |
| 19 |
UNIVERSITEIT UTRECHT
Organization address
address: Heidelberglaan 8 contact info |
NL (UTRECHT) | participant | 299˙000.00 |
| 20 |
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
Organization address
address: Piazzale Aldo Moro 5 contact info |
IT (ROMA) | participant | 298˙920.00 |
| 21 |
COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH
Organization address
address: "Meiring Naude Road, Brummeria 46" contact info |
ZA (PRETORIA) | participant | 296˙568.00 |
| 22 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 296˙360.00 |
| 23 |
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
Organization address
address: Via Olgettina 60 contact info |
IT (MILANO) | participant | 231˙548.00 |
| 24 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | participant | 203˙896.80 |
| 25 |
MINERVA CONSULTING & COMMUNICATION
Organization address
address: Av. de Tervuren 32-34 contact info |
BE (BRUSSELS) | participant | 200˙560.00 |
| 26 |
MICROBIOTEC srl
Organization address
address: Via delle Vigne 12 contact info |
IT (Monteriggioni (SI)) | participant | 198˙000.00 |
| 27 |
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH
Organization address
address: DONAUSTRASSE 99 contact info |
AT (KLOSTERNEUBURG) | participant | 109˙000.00 |
| 28 |
STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT
Organization address
address: PIETERSBERGWEG 17 TRINITY C 3E contact info |
NL (AMSTERDAM ZUIDOOST) | participant | 58˙048.90 |
| 29 |
JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA
Organization address
address: TURNHOUTSEWEG 30 contact info |
BE (BEERSE) | participant | 50˙000.00 |
| 30 |
THE UNIVERSITY OF LIVERPOOL
Organization address
address: Brownlow Hill, Foundation Building 765 contact info |
UK (LIVERPOOL) | participant | 41˙950.69 |
| 31 |
EUROPEAN AIDS TREATMENT GROUP EV
Organization address
address: METTMANNER STRASSE 24-26 contact info |
DE (DUSSELDORF) | participant | 33˙000.00 |
| 32 |
Nome Ente NON disponibile
Organization address
address: Chemin des Aulx 14 contact info |
CH (Plan-Les-Ouates) | participant | 0.00 |
| 33 |
"International Partnership for Microbicides, INC"
Organization address
address: "8401 Colesville Road, Suite 200" contact info |
US (Silver Spring) | participant | 0.00 |
| 34 |
GILEAD SCIENCES INC
Organization address
address: Lakeside Drive 333 contact info |
US (FOSTER CITY) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'This proposal is for a large scale collaborative project in which we propose both to develop novel microbicides directed against new intracellular targets and to investigate novel combinations of highly active anti-retroviral drugs which may be particularly effective as microbicides. Combinations may enhance efficacy but equally importantly will increase the genetic barrier to the development of resistance. The proposal includes development of both slow release and gel formulations, pharmacokinetic and challenge experiments in macaques as well as human studies including a collaborative study with an EDCTP-funded project to use multiplex and proteomic technologies as well as culture-independent DNA-based analysis of mucosal microbiota to investigate biomarkers and establish a baseline signature from which perturbations can be recognised. This is a large consortium comprising 30 partners from 8 EU countries and from Switzerland, Ukraine, South Africa and the United States.Partners include microbicide developers, IPM and Particle Sciences, and producers, Gilead, Tibotec and Virco. Two SMEs will also participate in RTD aspects. The consortium is multidisciplinary with scientists engaged in basic discovery working with new targets and developing novel chemistry to produce compounds with improved safety and efficacy profiles as well as altered patterns of resistance.'